LEX-WK-NX2G6R7Ycrawled 2021-10-27 12:22Z
S.D.N.Y. Preliminarily Approves $1.6 Million Settlement in Class Action Concerning Development of an OxyContin Alternative
Gregg Weiner · Adam Harris · Life Sciences Litigation & Enforcement Team · Life Sciences Securities Litigation · Published July 17, 2020
Work details
- firm or organization
- Ropes & Gray
- publication
- Life Sciences Securities Litigation
- practice area
- Banking, Finance and Securities
- published
- 2020-07-17
Citation
Gregg Weiner, Adam Harris, Life Sciences Litigation & Enforcement Team, S.D.N.Y. Preliminarily Approves $1.6 Million Settlement in Class Action Concerning Development of an OxyContin Alternative, Life Sciences Securities Litigation (July 17, 2020) [The Library at LexBlog, LEX-WK-NX2G6R7Y, lexpid.org/NX2G6R7Y]